2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness
Related Posts
Shah PD, Yeremian S, Forte E, Park D, Choi E, Qi J, Nguyen A, Akhtari M. EXPRESS: A Meta-analysis Reporting the Most Common Infectious Complications[...]
Hoque A, Barforoshi S, Megowan N. Giant Coronary Artery Aneurysm at the Left Main Bifurcation Managed With Stent-Assisted Endovascular Coil Embolization. JACC Case Rep. 2026[...]
Guterman EL, Dulaney SA, Sawyer RJ, Hanson LR, Olney N, Hess M, Lum HD, Brickell E, Rosenbloom M, Ward KT, Wood AJ, Allen IE, Scheffler[...]